For the Inventor, By the Inventor

Enter assignee name

Amsterdam, Netherlands

Academisch Medisch Centrum

USPTO Granted Patents = 28

% Expired Patents = 17.9

CIPO Patents = 5

EPO Patents = 14

Forward Citations = 154

Loading Chart...

Loading Chart...

56 inventors (with patents filed for the assignee):

Willem Meindert De Vos (5 out of 19 patents)

Max Nieuwdorp (5 out of 5 patents)

Johannes Maria Franciscus Gerardus Aerts (3 out of 9 patents)

4. Stan Van Boeckel (2 out of 5 patents)

5. Antonius Van Leeuwen (2 out of 2 patents)

6. Frank Coumans (2 out of 2 patents)

7. Nicolás Weiss (2 out of 2 patents)

8. Bakiye Imran Avci (2 out of 2 patents)

9. Herman Steven Overkleeft (2 out of 6 patents)

10. Amar Ghisaidoobe (2 out of 2 patents)

11. Richard Van Den Berg (2 out of 2 patents)

12. Max Medina-Ramirez (1 out of 1 patent)

13. Rogier Sanders (1 out of 2 patents)

14. Christian Jorgensen (1 out of 2 patents)

15. Nicole Neeltje Van Der Wel (1 out of 1 patent)

Core Competencies:

Diabetes Mellitus

Autoimmune Disease

Inflammatory Disease

HIV Immunogens

Neuromodulation Device

Optical Coherence Tomography

Antimicrobial Peptide

Gene Therapy

28 patents: Sort by Forward Citations

1. 12766168 - Fecal matter for treatment of cachexia (2026-10-20),

2. 12648928 - INTERVENTION STRATEGY FOR PREVENTION OR TREATMENT OF DIABETES MELLITUS, AUTOIMMUNE DISEASE, INFLAMMATORY DISEASE OR CARDIOVASCULAR DISEASE (2026-06-09),

3. 11650212 - Screening method for cerebrotendinous xanthomatosis using bile alcohol glucuronides and metabolite ratios (2023-05-16),

4. 11648287 - Composition for the treatment of intracellular bacterial infection (2023-05-16),

5. 11534465 - Fecal matter for treatment of autoimmune diseases (2022-12-27),

6. 11504243 - Device and method for determination of the moment-induced movement of a joint implant (2022-11-22),

7. 11344618 - HIV envelope glycoprotein immunogens (2022-05-31),

8. 11103504 - Combination of a DNA condensation-inducing compound and an Eis inhibitor for antibiotic treatment (2021-08-31),

9. 11067381 - Common-path integrated low coherence interferometry system and method therefor (2021-07-20),

10. 10974041 - Neuromodulation device (2021-04-13),

11. 10914634 - High-resolution integrated-optics-based spectrometer (2021-02-09),

12. 10907951 - Single-chip optical coherence tomography device (2021-02-02),

13. 10753724 - Common-path integrated low coherence interferometry system and method therefor (2020-08-25),

14. 10590082 - N-(5-((aryl or heteroaryl)methyloxy)pentyl)-substituted iminosugars as inhibitors of glucosylceramide synthase (2020-03-17),

15. 10456439 - NK3 agonist for use in the treatment of a patient suffering from atrial arrhythmia or fibrillation (2019-10-29),

Company Overview

Academisch Medisch Centrum (AMC) is a leading academic medical center located in Amsterdam, specializing in patient care, research, and education. The institution is renowned for its comprehensive healthcare services and innovative research across various medical fields, including oncology, cardiology, and neurology. AMC collaborates with multiple partners to advance medical knowledge and improve treatment methodologies, contributing significantly to the healthcare landscape in the Netherlands and beyond.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

28 Patents

#27 in Amsterdam

#265 in Netherlands

#23,299 in the World

Amsterdam, Netherlands

Academisch Medisch Centrum

Forward Citations = 154

56 inventors:

Willem Meindert De Vos (5 out of 19 patents)

Max Nieuwdorp (5 out of 5 patents)

Johannes Maria Franciscus Gerardus Aerts (3 out of 9 patents)

4. Stan Van Boeckel (2 out of 5 patents)

5. Antonius Van Leeuwen (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Academisch Medisch Centrum. Retrieved from https://idiyas.com/company/academisch-medisch-centrum

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…